Current Developments in Urogenital Infections
A special issue of Microorganisms (ISSN 2076-2607). This special issue belongs to the section "Medical Microbiology".
Deadline for manuscript submissions: 30 April 2025 | Viewed by 372
Special Issue Editors
Interests: sepsis; COVID-19; immunology of infection
Special Issues, Collections and Topics in MDPI journals
Interests: HIV, sepsis; COVID-19; multi-drug-resistant pathogens; urogenital infections; immunology of infection
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Urogenital infections represent a significant burden on global public health, affecting millions of individuals worldwide. From urinary tract infections (UTIs) to sexually transmitted infections (STIs) and genital tract infections (GTIs), these conditions pose challenges in diagnosis, treatment, and prevention. As our understanding of the complex interactions between pathogens and the urogenital system deepens, new avenues for research and innovation emerge. We are please to invite you to contribute to this Special Issue of Microorganisms entitled “Current Developments in Urogenital Infections”. This Special Issue aims to provide a comprehensive overview of recent developments in the field of urogenital infections, encompassing a wide range of topics from basic science to clinical applications.
In this Special Issue, original research articles and reviews are welcome. Research areas may include (but are not limited to) the following:
- Pathogenesis and microbiology: Insights into the mechanisms of pathogen colonization and invasion in the urogenital tract. Emerging pathogens and antimicrobial resistance patterns in urogenital infections. Microbiota dynamics and their impact on urogenital health and disease.
- Diagnostic innovations: Novel approaches for the rapid and accurate diagnosis of urogenital infections. Biomarkers and molecular techniques for detecting specific pathogens and assessing disease severity.
- Therapeutic strategies: Advancements in antimicrobial agents for the treatment of urogenital infections. Precision medicine approaches tailored to individual patient profiles and microbial susceptibilities. Alternative and adjunctive therapies, including probiotics and phage therapy.
- Prevention: Strategies for the prevention of urogenital infections, including vaccination and behavior modification. Screening programs and risk assessment tools for identifying high-risk populations.
- Interdisciplinary perspectives: Integration of genomics, proteomics, and bioinformatics in urogenital infection research. Collaboration between microbiologists, clinicians, epidemiologists, and public health experts to address complex challenges.
- By synthesizing the latest research findings and fostering interdisciplinary dialogue, this Special Issue aims to advance our understanding of urogenital infections and facilitate the translation of scientific discoveries into clinical practice. We invite researchers, clinicians, and public health professionals to contribute their insights and expertise to this collaborative endeavor. "Current Developments in Urogenital Infections" represents a timely opportunity to showcase groundbreaking research and innovations that are shaping the future of urogenital health. Through a multidisciplinary approach, we aim to address the evolving challenges posed by urogenital infections and ultimately improve patient outcomes and public health interventions. We look forward to a vibrant exchange of ideas and discoveries in this exciting field.
Prof. Dr. Charalambos Gogos
Dr. Karolina Akinosoglou
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Microorganisms is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- urinary tract infection
- genital tract infection
- sexually transmitted disease
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.
